149 related articles for article (PubMed ID: 18035686)
1. [Tumours and inflammatory liver diseases].
Wittekind Ch
Verh Dtsch Ges Pathol; 2005; 89():163-8. PubMed ID: 18035686
[TBL] [Abstract][Full Text] [Related]
2. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B.
Koo JS; Kim H; Park BK; Ahn SH; Han KH; Chon CY; Park C; Park YN
J Clin Gastroenterol; 2008 Jul; 42(6):738-43. PubMed ID: 18277883
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease.
Gressner OA; Jafari S; Erkens M; Gao C; Stanzel S; Gressner AM
Clin Chim Acta; 2009 May; 403(1-2):188-93. PubMed ID: 19281805
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
Kara B; Doran F; Kara IO; Akkiz H; Sandikci M
Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
[TBL] [Abstract][Full Text] [Related]
6. A multistep approach in the cytologic evaluation of liver biopsy samples of dogs with hepatic diseases.
Stockhaus C; Van Den Ingh T; Rothuizen J; Teske E
Vet Pathol; 2004 Sep; 41(5):461-70. PubMed ID: 15347818
[TBL] [Abstract][Full Text] [Related]
7. Human binucleate hepatocytes: are they a defence during chronic liver diseases?
Grizzi F; Chiriva-Internati M
Med Hypotheses; 2007; 69(2):258-61. PubMed ID: 17307305
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapies and targeted therapies in advanced hepatocellular carcinoma: from laboratory to clinic.
Voiculescu M; Winkler RE; Moscovici M; Neuman MG
J Gastrointestin Liver Dis; 2008 Sep; 17(3):315-22. PubMed ID: 18836626
[TBL] [Abstract][Full Text] [Related]
9. Liver regeneration, liver cancers and cyclins.
Kitamura T; Watanabe S; Sato N
J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S96-9. PubMed ID: 9792041
[TBL] [Abstract][Full Text] [Related]
10. Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus.
Konishi I; Hiasa Y; Shigematsu S; Hirooka M; Furukawa S; Abe M; Matsuura B; Michitaka K; Horiike N; Onji M
Liver Int; 2009 Sep; 29(8):1194-201. PubMed ID: 19422477
[TBL] [Abstract][Full Text] [Related]
11. Histopathological classification of hepatocellular carcinoma.
Roncalli M; Park YN; Di Tommaso L
Dig Liver Dis; 2010 Jul; 42 Suppl 3():S228-34. PubMed ID: 20547308
[TBL] [Abstract][Full Text] [Related]
12. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
13. HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis.
Sagmeister S; Drucker C; Losert A; Grusch M; Daryabeigi A; Parzefall W; Rohr-Udilova N; Bichler C; Smedsrød B; Kandioler D; Grünberger T; Wrba F; Schulte-Hermann R; Grasl-Kraupp B
J Hepatol; 2008 Dec; 49(6):955-64. PubMed ID: 18929421
[TBL] [Abstract][Full Text] [Related]
14. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients.
Ohki T; Tateishi R; Sato T; Masuzaki R; Imamura J; Goto T; Yamashiki N; Yoshida H; Kanai F; Kato N; Shiina S; Yoshida H; Kawabe T; Omata M
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):459-64. PubMed ID: 18387499
[TBL] [Abstract][Full Text] [Related]
15. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
16. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
Bortolami M; Kotsafti A; Cardin R; Farinati F
J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
[TBL] [Abstract][Full Text] [Related]
17. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
18. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus induced hepatocellular carcinoma.
Chemin I; Zoulim F
Cancer Lett; 2009 Dec; 286(1):52-9. PubMed ID: 19147276
[TBL] [Abstract][Full Text] [Related]
20. Cytophotometric estimation of hepatocytes DNA in chronic liver diseases including schistosomiasis for detection of early preneoplastic changes.
Abdel Rahman MM; el-Hakim MS; Ahmed MK; Saleh SA; el Sayed G el-D ; Arafa MM
J Egypt Soc Parasitol; 1994 Dec; 24(3):633-41. PubMed ID: 7844429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
